Cooperative interaction between c-myc and bcl-2 proto-oncogenes
- 8 October 1992
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 359 (6395), 554-556
- https://doi.org/10.1038/359554a0
Abstract
THE bcl-2 proto-oncogene is activated by translocation in a variety of B-lymphoid tumours and synergizes with the c-myc oncogene in tumour progression1. The mechanism of synergy is unclear but bcl-2 expression inhibits apoptosis2–6, a property presumably pertinent to its proto-oncogenic mode of action4. We have shown that the c-myc gene is a potent inducer of apoptosis, in addition to its established role in mitogenesis7. Here we show that expression of the bcl-2 protein, Bcl-2, specifically abrogates c-mvoinduced apoptosis without affecting the c-myc mitogenic function. This provides a novel mechanism for oncogene cooperation, of potential importance both in carcinogenesis and in the evolution of drug resistance in tumours.Keywords
This publication has 20 references indexed in Scilit:
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- bcl-2 transgene inhibits T cell death and perturbs thymic self-censorshipCell, 1991
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991
- Genetic Mechanisms of Drug Resistance: A ReviewActa Oncologica, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- The biochemistry of cell death by apoptosisBiochemistry and Cell Biology, 1990
- Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cellsNature, 1989
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Apoptosis: Cell death in tissue regulationThe Journal of Pathology, 1987
- Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenesNature, 1983